Publications

 Park JH, Jung K, Jia D, Yang S, Attri S, Ahn S, Mourthy D, Samanta T, Dutta D, Ghidey M, Chatterjee S, Han SY, Pedroza DA, Tiwari A, Lee JV, Davis C, Li S, Putluri V, Creighton C, Putluri N, Dobrolecki  LE, Lewis MT, Rosen JM, Onuchic JN, Goga A, Kaipparettu BA* (2025).  Biguanides antithetically regulate tumor properties by the dose-dependent mitochondrial reprogramming-driven c-Src pathway. Cell Reports Medicine (In Press).

Viola V, Samanta T, Duremdes Nava ML, Celli A, Armamento-Villareal R, Nguyen NHL, Colleluori G, Barnouin Y, Napoli N, Qualls C, Kaipparettu BA, Villareal DT (2024). Testosterone Modulation of Muscle Transcriptomic Profile during Lifestyle Therapy in Older Men with Obesity and Hypogonadism. Journal of Cachexia, Sarcopenia and Muscle (In Press).

Kami Reddy KR, Piyarathna DWB, Park HJ, Putluri V, Amara CS, Kamal AHM, Xu J, Kraushaar D, Huang S, Jung SY, Eberlin LS, Kittles R, Ballester LY, Parsawar K, Siddiqui MM, Gao J, Bollag RJ, Terris MK, Lotan Y, Creighton CJ, Lerner SP, Sreekumar A, Kaipparettu BA*, Putluri N* (2024). Mitochondrial reprogramming by activation of oxidative phosphorylation via glutamine-metabolism in bladder tumors of African American patients. JCI Insight Sep 10;9(17):e172336. doi: 10.1172/jci.insight.172336.

Dutta D*, Hoque AA, Paul B, Park HJ, Chowdhury C, Quadir M, Banerjee S, Choudhury A, Laha S, Sepay N, Boro P, Kaipparettu BA*, Mukherjee B* (2024). EpCAM-targeted betulinic acid analogue nanotherapy improves therapeutic efficacy and induces anti-tumorigenic immune response in colorectal cancer tumor microenvironment. Journal of Biomedical Science Aug 20;31(1):81. doi: 10.1186/s12929-024-01069-8.

Oturkar CC, Rosario S, Hutson AD, Groman A, Edge SB, Morrison CD, Swetzig WM, Wang J, Park HJ, Kaipparettu BA, Singh PK, Kumar S, Cappucino HH, Ranjan M, Adjei A, Ghasemi M, Goey AK, Kulkarni SA, Das GM (2024). ESR1 and p53 interactome defines mechanisms of therapeutic response to tamoxifen therapy in luminal breast cancer patients. iScience 15;27(6):109995.

Murthy D, Dutta D, Attri K, Samanta T, Yang S, Jung KH, Latario SG, Putluri V, Huang S, Putluri N, Park JH*, Kaipparettu BA* (2024). CD24 negativity reprograms mitochondrial metabolism to PPARa and NF-kB-driven fatty acid B-oxidation in triple-negative breast cancer. Cancer Letters Feb 17;587:216724. 

Ahn S, Park JH, Grimm SL, Badrajee PDW, Samanta T, Putluri V, Mezquita D, Fuqua SAW, Putluri N, Coarfa C*, Kaipparettu BA* (2024). Metabolomic rewiring promotes endocrine therapy resistance in breast cancer. Cancer Research Jan 16;84(2):291-304.

Alula KM, Dowdell A, LeBere B, Lee S, Levins CL, Kuhn KA, Kaipparettu BA, Thompson WE, Blumberg RS, Colgan SP, Theiss AL (2023). Interplay of gut microbiota and host epithelial mitochondrial dysfunction is necessary for the development of spontaneous intestinal inflammation in mice. Microbiome Nov 17;11(1):256. 

Dutta D, Kanca O, Byeon SK, Marcogliese PC, Zuo Z, Shridharan RV, Park JH, Undiagnosed Diseases Network, Lin G, Ge M, Heimer G, Kohler JN, Wheeler MT, Kaipparettu BA, Pandey A, Bellen HJ (2023). A defect in mitochondrial fatty acid synthesis impairs iron metabolism and causes elevated ceramide levels. Nature Metabolism 5(9):1595-1614. 

Masschelin PM, Saha P, Ochsner SA, Cox AR, Kim KH, Felix JB, Sharp R, Li X, Tan L, Park JH, Wang L, Putluri V, Lorenzi PL, Nuotio-Antar AM, Sun Z, Kaipparettu BA, Putluri N, Moore DD, Summers SA, McKenna NJ, Hartig SM (2023). Vitamin B2 enables regulation of fasting glucose availability. Elife. 7;12:e84077. doi: 10.7554/eLife.84077.

Hoque AA, Dutta D, Paula B, Kumari L, Ehsan I, Dhara M, Mukherjee B, Quadir M, Kaipparettu BA, Laha S, Ganguly S (2023). ΔPSap4#5-surface functionalized abiraterone-loaded nanoparticle successfully inhibits carcinogen-induced prostate cancer in mice: a mechanistic investigation. Cancer Nanotechnology. doi.org/10.1186/s12645-023-00223-5.

Abdulkareem NM, Bhat R, Powell RT, Chikermane S, Yande S, Trinh L, Abdelnasser HY, Tabassum M, Ruiz A, Sobieski M, Nguyen N, Park JH, Johnson CA, Kaipparettu BA, Bond RA, Johnson M, Stephan C, Trivedi MV (2022). Screening of GPCR drugs for repurposing in breast cancer. Frontiers in Pharmacology 13:1049640: 1-14.

Attri KS, Park JH,  Kaipparettu BA* (2022). (Editorial) Redox regulation of hybrid metabolic state in breast cancer metastasis. Annals of Translational Medicine 10(18):1032: 1-4.

Rajamanickam S, Park JH, Bates K, Yadav P, Subbarayalu P, Timilsina S, Eedunuri VK, Mohammad TA, Jung KH, Onyeagucha B, Abdelfattah N, Benevides R, Lee G, Chen Y, Vadlamudi RK, Brenner A, Kaklamani V, Jatoi I, Kuhn J, Hromas R, Gupta YK,  Kaipparettu BA , Arbiser JL, Rao MK (2022). Targeting aberrant replication and DNA repair events for triple negative breast cancer. Communications Biology May 24;5(1):493.

Tripathi S, Park JH, Pudakalakatti S, Bhattacharya P, Kaipparettu BA, Levine H (2022). A mechanistic modeling framework reveals the key principles underlying tumor metabolism. PLOS Computational Biology Feb 11;18(2):e1009841.

Jewell BE, Xu A, Zhu D, Huang MF, Lu L, Liu M, Underwood EL, Park JH, Fan H, Gingold JA, Zhou R, Tu J, Huo Z, Liu Y, Jin W, Chen YH, Xu Y, Chen SH, Rainusso N, Berg NK, Bazer DA, Vellano C, Jones P, Eltzschig HK, Zhao Z, Kaipparettu BA, Zhao R, Wang LL, Lee DF (2021). Patient-derived iPSCs Link Elevated Mitochondrial Respiratory Complex I Function to Osteosarcoma in Rothmund-Thomson Syndrome PLOS Genetics  Dec 29;17(12):e1009971.  

Singh S, Kanika, Kedawat  G, Park JH, Ghorai B, Ghorai UK, Upadhyay C, Kaipparettu BA, Gupta BK (2021). Journal of Photochemistry and Photobiology. https://doi.org/10.1016/j.jpap.2021.100081.

Alula KM, Jackson DN, Smith AD, Kim DS, Turner K, Odstrcil E, Kaipparettu BK, Dassopoulos T, Venuprasad K, Feagins LA, Theiss AL (2021).  Targeting mitochondrial damage as a therapeutic for ileal Crohn’s disease. Cells May 29;10(6):1349. 

Jia D*, Park JH, Kaur H, Jung KH, Yang S, Tripathi S, Galbraith M, Deng Y, Jolly MK, u L, Kaipparettu BA*, Onuchic J*, Levine H* (2021). Towards decoding the coupled decision-making of metabolism and epithelial-mesenchymal transition in cancer. Br J Cancer, Jun;124(12):1902-1911. 

Sarkar A, Stellrecht CM, Vangapandu HV, Ayres M, Kaipparettu BA, Park HJ, Balakrishnan K, Burks JK, Pandita TK, Hittelman WN, Neelapu SS, Gandhi V (2020). ATM interacts with Parkin and induces mitophagy independent of ATM kinase activity: Evidence from mantle cell lymphoma. Haematologica  Feb 1;106(2):495-512.

Chen CJ, Sgritta M, Mays J,  Zhou H,  Lucero R, Park J, Wang IC, Park PK, Kaipparettu BA, Stoica L, Jafar-Nejad P, Rigo F,  Chin J, Noebels JL, Costa-Mattioli M (2019). Therapeutic inhibition of mTORC2 rescues the behavioral and neurophysiological abnormalities associated with Pten-deficiency. Nature Medicine 25 (11), 1684-1690.  

Colleluori G, Aguirre L, Phadnis U, Fowler K, Armamento-Villareal R, Sun Z, Brunetti L, Kaipparettu BA, Park JH, Putluri N, Auetumrongsawat V, Yarasheski K, Qualls C, Villareal DT (2019). Aerobic plus Resistance Training in Dieting Obese Older Adults Improves Muscle Protein Synthesis and Preserves Myocellular Quality Despite Energy Deficit. Cell Metabolism Aug 6:30(2):261-273 (Cover image of the journal). 

Mukhopadhyay UK, Oturkar CC,  Adams  C, Wickramasekera N, Bansal S, Medisetty R,  Miller A, Swetzig WM, Silwal-Pandit L, Borresen-Dale AL, Creighton CJ, Park JH, Konduri SD, Mukhopadhyay A, Caradori A, Omilian A, Bshara W, Kaipparettu BA & Das M (2019). p53 Status as a Determinant of Pro-versus Ant-tumorigenic Effects of Estrogen Receptor β in Breast Cancer The Journal of the National Cancer Institute (JNCI) Apr 16. pii: djz051. doi: 10.1093/jnci/djz051. 

Dutta P, Salzillo TC, Pudakalakatti S, Gammon ST, Kaipparettu BA, McAllister F, Wagner S, Frigo DE,  Logothetis CJ,  Zacharias NM and Bhattacharya PK (2019). Assessing Therapeutic Efficacy in Real-time by Hyperpolarized Magnetic Resonance Metabolic Imaging. Cells 2019, 8(4), 340; https://doi.org/10.3390/cells8040340.

Jia D, Lu M, Jung KH, Park JH, Yu L, Onuchic J*, Kaipparettu BA*, Levine H*  (2019). Elucidating Cancer Metabolic Plasticity by Coupling Gene Regulation with Metabolic Pathways. Proceedings of the National Academy of Sciences (PNAS) Feb 7. 116 (9), 3909-3918.

Radhakrishnan S, Park JH, Neupane R, Reyes CL, Sudeep PM, Paulose M, Marti AA, Tiwary CS, Khabashesku VN, Varghese OK*, Kaipparettu BK*, Ajayan PM* (2018). Fluorinated Boron Nitride Quantum Dots: A New Zero-dimensional Material for Energy Conversion and Detection of Cellular Metabolism.Particle and Particle System Characterization DOI: 10.1002/ppsc.201800346

Jia D, Park JH, Jung KH, Levine H, Kaipparettu BA* (2018). Elucidating the Metabolic Plasticity of Cancer: Mitochondrial reprogramming and hybrid metabolic states. Cells 7(3), 21; doi:10.3390/cells7030021.

Chipara AC, Tsafack T, Owuor PS, Yeon , Junkermeier JE, Duin ACT, Bhowmick S, Asif SAS, Radhakrishnan S, Park JH, Brunetto G, Kaipparettu BA, Galvão DS, Chipara M, Lou J, Tsang HH, Dubey M, Vajtai R, Tiwary CS, Ajayan PM (2018). Underwater adhesive using solid-liquid polymer mixes. Materials Today Chemistry Sept; (9):149-57.

Owuor PS, Tsafack T, Agrawal H, Hwang HY, Zelisko M, Li T, Radhakrishnan S, Park JH, Yang Y, Stender AS, Ozden S, Joyner J, Vajtai R, Kaipparettu BA, Wei B, Lou J, Sharma P, Tiwary CS, Ajayan PM (2018). Poly-albumen: Bio-derived structural polymer from polymerized egg white. Materials Today Chemistry Sept; (9):73-79

Zhao N, Cao J, Xu L, Tang Q, Dobrolecki LE, Lv X, Talukdar M, Lu Y, Wang X, Hu DZ, Shi Q, Xiang Y, Wang Y, Liu X, Bu W, Jiang Y, Li M, Gong Y, Sun Z, Ying H, Yuan B, Lin X, Feng XH, Hartig SM, Li F, Shen H, Chen Y, Han L, Zeng Q, Patterson JB, Kaipparettu BA, Putluri N, Sicheri F, Rosen JM, Lewis MT, Chen X (2018). Pharmacological targeting of MYC-regulated IRE1/XBP1 pathway suppresses MYC-driven breast cancer. The Journal of Clinical Investigation Feb 26. pii: 95873. doi: 10.1172/JCI95873.

White MA, Tsouko E, Lin C, Rajapakshe K, Spencer JM, Wilkenfeld SR, Vakili SS, Pulliam TL, Awad D, Nikolos F, Katreddy RR, Kaipparettu BA, Sreekumar A, Zhang X, Cheung E, Coarfa C and Frigo DE (2018). GLUT12 promotes prostate cancer cell growth and is regulated by androgens and CaMKK2 signaling. Endocrine Related Cancer 25 (4), 453-469.

 Yu L, Lu M*, Jia D, Ma J, Ben-Jacob E, Levine H, Kaipparettu BA*, Onuchic J* (2017). Modeling the Genetic Regulation of Cancer Metabolism: Interplay Between Glycolysis and Oxidative Phosphorylation. Cancer Research Apr 1;77(7):1564-1574.

Vangapandu H, Havranek O, Ayres M, Kaipparettu BK, Balakrishnan K, Wierda W, Keating M, Davis E, Stellrecht C, and Gandhi V (2017). B cell receptor signaling regulates metabolism in Chronic Lymphocytic Leukemia. Molecular Cancer Research Dec;15(12):1692-1703. 

Jin F, Thaiparambil J, Donepudi R, Vantaku V, Piyarathna DWB, Maity S, Krishnapuram R, Putluri V, Gu F, Purwaha P, Bhowmik S, Ambati CR, Rundstedt FC, Roghmann F, Berg S, Noldus J, Rajapakshe K, Gödde D, Roth S, Störkel S, Degener S, Michailidis G, Kaipparettu BA, Karanam B, Terris MK, Kavuri SM, Lerner SP, Kheradmand F, Coarfa C, Sreekumar A, Lotan Y, El-Zein R, Putluri N (2017). Tobacco-specific carcinogens induce hypermethylation, DNA adducts and DNA damage in Bladder Cancer. Cancer Prevention Research Aug 29. doi: 10.1158/1940-6207.

Gupta BK*, Kumara P,  Singh S, Kedawat G, Vithayathil SA, Gangwara AK, Singh S, Kashyapa PK, Lahona R, Singh VN, Deshmukhe AD, Narayanan TN, Singh N, Gupta S, Kaipparettu BA* (2017). Tunable luminescence from two dimensional BCNO nanophosphor for high-contrast cellular imaging. RSC Advances  7, 41486-94.

Radhakrishnan S, Sudeep PM, Park JH, Woellner CF, Maladonado K, Galvao DS, Kaipparettu BK, Tiwary CS, Ajayan PM (2017). Multifunctional Hybrid based on 2D Fluorinated Graphene Oxide and SPION. Particle and Particle System Characterization DOI: 10.1002/ppsc.201700245.

Yu L, Lu M*, Jia D, Ma J, Ben-Jacob E, Levine H, Kaipparettu BA*, Onuchic J* (Joint lab project) (2017). Modeling the Genetic Regulation of Cancer Metabolism: Interplay Between Glycolysis and Oxidative Phosphorylation. Cancer Research. April 1; 77(7):1564-1574.   

Gupta BK*, Singh S,  Kumar P, Lee Y, Kedawat G, Narayanan T, Vithayathil SA, Ge L, Zhan X, Gupta S, Marti A, Vajtai R, Ajayan PM, Kaipparettu BA* (2016). Bifunctional luminomagnetic rare-earth nanorods for high-contrast bioimaging nanoprobes. Scientific Reports.  Sep 2;6:32401. doi: 10.1038/srep32401.

Kaushik AK, Shojaie A, Panzitt K, Sonavane R, Venghatakrishnan H, Manikkam M, Zaslavsky A, Putluri  V, Vasu VT, Zhang Y, Khan AS, Lloyd S, Szafran AT, Dasgupta S, Bader DA, Stossi F, Li H, Samanta S, Cao X, Tsouko E, Huang S, Frigo DE, Chan L, Edwards D, Kaipparettu BA, Mitsiades N, Weigel NL, Mancini M, McGuire SE, Mehra R, Ittmann MM, Chinnaiyan AM, Putluri N, Palapattu GS, Michailidis G, Sreekumar A (2016). Inhibition of the hexosamine biosynthetic pathway promotes castration-resistant prostate cancer. Nature Communication. May 19;7:11612. doi: 10.1038/ncomms11612.

Singh S, Kumar P, Kaipparettu BA*, Gupta BK* (2016). Eu3+ doped α-sodium gadolinium fluoride luminomagnetic nanophosphor as a bimodal nanoprobe for high-contrast in vitro bioimaging and external magnetic field tracking applications. RSC Advances. 6, 44606-doi: 4461510.1039/C6RA04373A. 

 Liang DH, Choi DS, Ensor JE, Kaipparettu BA, Bass BL, Chang JC (2016). The autophagy inhibitor chloroquine targets cancer stem cells in triple negative breast cancer by inducing mitochondrial damage and impairing DNA break repair. Cancer Lett. Apr 6. pii: S0304-3835(16)30215-4.

Park JH, Vithayathil S, Kumar S, Sung PL, Dobrolecki LE, Putluri V, Bhat VB, Bhowmik SK, Gupta V, Arora K, Wu D, Tsouko E, Zhang Y, Maity S, Donti TR, Graham BH, Frigo DE, Coarfa C, Yotnda P, Putluri N, Sreekumar A, Lewis MT, Creighton CJ, Wong LC*, Kaipparettu BA* (2016). Fatty Acid Oxidation-Driven Src Links Mitochondrial Energy Reprogramming and Oncogenic Properties in Triple-Negative Breast Cancer. Cell Reports. Mar 8;14(9):2154-65. doi: 10.1016/j.celrep.2016.02.004.

Chen F, Zhang Y,  Şenbabaoğlu Y,  Ciriello G, Yang L, Reznik E,  Shuch B, Micevic G,  Velasco GD, Shinbrot E, Noble MS, Lu Y, Covington KR, Xi L, Drummond JA, Muzny D, Kang H, Lee J, Tamboli P, Reuter V, Shelley CS, Kaipparettu BA, Bottaro DP, Godwin AK, Gibbs RA, Getz G, Kucherlapati R, Park PJ, Sander C, Henske EP, Zhou JH, Kwiatkowski DJ, Ho TH, Choueiri TK, Hsieh JJ,   Akbani R,  Mills GB,  Hakimi AA, Wheeler DA, Creighton CJ (2016).  Multilevel Genomics-Based Taxonomy of Renal Cell Carcinoma. Cell Reports. Mar 15;14(10):2476-89. doi: 10.1016/j.celrep.2016.02.024.

Saraf M, Kumar P, Kedawat G, Dwivedi J, Vithayathil SA, Jaiswal N, Kaipparettu BA, Gupta BK (2015). Probing highly luminescent europium-doped lanthanum orthophosphate nanorods for strategic applications. Inorg Chem.  Mar 16;54(6):2616-25

Davis CF, Ricketts CJ, Wang M, Yang L, Cherniack AD, Shen H, Buhay C, Kang H, Kim SC, Fahey CC, Hacker KE, Bhanot G, Gordenin DA, Chu A, Gunaratne PH, Biehl M, Seth S, Kaipparettu BA, Bristow CA, Donehower LA, Wallen EM, Smith AB, Tickoo SK, Tamboli P, Reuter V, Schmidt LS, Hsieh JJ, Choueiri TK, Hakimi AA; Cancer Genome Atlas Research Network, Chin L, Meyerson M, Kucherlapati R, Park WY, Robertson AG, Laird PW, Henske EP, Kwiatkowski DJ, Park PJ, Morgan M, Shuch B, Muzny D, Wheeler DA, Linehan WM, Gibbs RA, Rathmell WK, Creighton CJ (2014). The somatic genomic landscape of chromophobe renal cell carcinoma. Cancer Cell. Sep 8;26(3):319-30. (Cover image of the journal).

Kaipparettu BA*, Ma Y, Park J, Lee T-L, Zhang Y, Yotnda P, Creighton C, Chan W-Y, Wong LJ* (2013). Cross talk from  noncancerous mitochondria can inhibit tumor properties of metastatic cells by suppressing oncogenic pathways. PLoS One 9;8(5):e61747.

Gupta BK, Narayanan TN, Vithayathil SA, Lee Y, Koshy S, Reddy AL, Saha A, Shanker V, Singh VN, Kaipparettu BA*, Martí AA, Ajayan PM* (2012). Highly Luminescent-Paramagnetic Nanophosphor Probes for In Vitro High-Contrast Imaging of Human Breast Cancer Cells. Small  8(19):3028-34. (IF: 8.39)

Narayanan N, Gupta BK, Vithayathil SA, Aburto RR, Mani SA, Taha-Tijerina J, Xie B, Kaipparettu BA*, Torti SV, and Ajayan PM* (2012). Hybrid 2D Nanomaterials as Dual-mode Contrast Agents in Cellular Imaging. Adv Mater 24(22):2992-8. (IF: 17.43)

Peng J, Gao W, Gupta BK, Liu Z, Romero-Aburto R, Ge L, Song L, Alemany LB, Zhan X, Gao G, Vithayathil SA, Kaipparettu BA, Marti AA, Hayashi T, Zhu JJ, Ajayan PM (2012). Graphene quantum dots derived from carbon fibers. Nano Lett 8;12(2):844-9. (IF: 13.59)

Vithayathil SA, Ma Y, Kaipparettu BA* (2012). Transmitochondrial cybrids: Tools for functional studies of mitochondria. Methods Mol Biol 837:219-30.Tu YF, Kaipparettu BA, Ma Y, Wong LJ (2011). Mitochondria of highly metastatic breast cancer cell line MDA-MB-231 exhibits increased autophagic properties. Biochim Biophys Acta 1807(9):1125-32. (IF: 4.38)

Konduria SD, Medisettya R, Liua W, Kaipparettu BA, Srivastava P, Brauch H, Fritz P, Swetziga WM, Gardnerf AE, Khanf SA, and Das GM (2010). Mechanisms of estrogen receptor antagonism toward p53: Implications in breast cancer therapeutic response and stem cell regulation. Proc. Natl. Acad. Sci 24;107:15081-6. (IF: 9.67)

Kaipparettu BA, Ma Y, Wong LJ (2010). Functional effects of cancer mitochondria on energy metabolism and tumorigenesis: utility of transmitochondrial cybrids. Ann NY Acad Sci 1201(1):137-46. (IF: 4.03)

Hammerich-Hille S, Kaipparettu BA (Shared first authors), Tsimelzon A, Creighton CJ, Jiang S, Polo JM, Melnick A, Meyer R, Oesterreich S (2010). SAFB1 mediates repression of immune regulators and apoptotic genes in breast cancer cells. J Biol Chem 285(6):3608-16.

Kaipparettu BA*, Dobrzycka KM, Britton O, Lee AV, Herron AJ, Li Y, Lewis MT, Medina M, Oesterreich S (2009). Scaffold attachment factor B1 (SAFB1) heterozygosity does not influence Wnt-1 or DMBA-induced tumorigenesis. Molecular Cancer 6;8:15.

Kaipparettu BA, Kuiatse I, Tak-Yee Chan B, Benny Kaipparettu M, Lee AV, Oesterreich S (2008). Novel egg white-based 3-D cell culture system. Biotechniques. 45(2):165-8. (Cover image of the journal, published as breaking news and rated by Faculty 1000).

Kaipparettu BA*, Malik S, Konduri SD, Liu W, Rokavec M, van der Kuip H, Hoppe R, Hammerich-Hille S, Fritz P, Schroth W, Abele I, Das GM, Oesterreich S, Brauch H (2008).. Estrogen-mediated downregulation of CD24 in breast cancer cells. Int J Cancer 123 (1):66-72.

Jaremko M, Justenhoven C, Schroth W, Abraham BK, Fritz, P, Vollmert C, Illig T, Simon W, Schwab M, Brauch H (2007). Polymorphism of the DNA repair enzyme XRCC1 is associated with treatment prediction in anthracycline and cyclophosphamide/methotrexate/5-fluorouracil-based chemotherapy of patients with primary invasive breast cancer. Pharmacogen Genom 17:529-38.

Jaremko M, Justenhoven C, Abraham BK, Schroth W, Fritz P, Brod S, Vollmert C, Illig T, Brauch H (2005). MALDI-TOF and TaqMan assisted SNP genotyping of DNA isolated from formalin-fixed and paraffin-embedded tissues (FFPET). Hum Mut 25:232-8.

Jose R, Chandrasekaran A, Sam SS, Gerard N, Chanolean S, Abraham BK, Satyanarayanamoorthy K, Peter A, Rajagopal K (2005). CYP2C9 and CYP2C19 genetic polymorphisms: Frequencies in the South Indian population. Fundam Clin Pharmacol 19:101-5.

Abraham BK, Fritz P, McClellann M, Hauptvogel P, Brauch H (2005). Prevalence of CD44+/CD24-/low cells in breast cancer may not be associated with clinical outcome but may favor distant metastasis. Clin Cancer Res 11:1154-9. (This highly cited article reported for the first time on the role of breast cancer stem cells in distant metastasis. Quote from a book: “In 2005, Abraham et al. were the first to publish a study on the prognostic applicability of the then newly identified breast CSC markers” (Cancer Stem Cells Theories and Practice. Edited by Stanley Shostak, 2011)

Abraham BK, Justenhobrn C, Pesch B, Harth V, Hamann U, Bruening and Brauch H for GENICA net work (2005). Investigation of genetic variants of genes of the Hemochromatosis pathway and their role in breast cancer. Cancer Epidemiol Biomarkers Prev 14:1102-7.

Naveen AT, Adithan C, Padmaja N, Shashindran CH, Abraham BK, Satyanarayanamoorthy K, Anitha P, Gerard N, Krishnamoorthy R (2004). Glutathione S-transferase M1 and T1 null genotype distribution in South Indians. Eur J Clin Pharmacol 60:403-6.

Koumaravelou K, Adithan C, Shashindran CH, Asad M, Abraham BK (2002). Effect of honey on carbamazepine kinetics in rabbits. Indian J Exp Biol 40:560-3.

Koumaravelou K, Adithan C, Shashindran CH, Asad M, Abraham BK (2002). Influence of honey on orally and intravenously administered diltiazem kinetics in rabbits. Indian J Exp Biol 40:1164-8.

Asad M, Shewade DG, Koumaravelou K, Abraham BK, Vasu S, Ramaswamy S (2001). Gastric anti-secretory and anti-ulcer activity of oxytocin in rats and Guinea pigs. Life Sciences 70:17-24.

Asad M, Shewade DG, Abraham BK, Koumaravelou K, Vasu S,Ramaswamy S (2001). Effect of centrally administered oxytocin on gastric and duodenal ulcers in rats. Acta Pharmacol Sin 22(6):488-92.

Asad M, Shewade DG, Koumaravelou K, Abraham BK, Vasu S, Ramaswamy S (2001). Effect of centrally administered prolactin on gastric and duodenal ulcers in rats. Fund Clin Pharmacol 3:175-9.

Asad M, Shewade DG, Abraham BK, Koumaravelou K, Balasinor N, Ramaswamy S (2001). Effect of hyperprolactinemia as induced by pituitary homografts under kidney capsule on gastric and duodenal ulcers. J Pharm Pharmacol 58:1541-7.

Abraham BK & Adithan C. (2001). Genetic polymorphism of CYP2D6. Ind J Pharmacol 33:147-69

Abraham BK, Adithan C, Mohanasundaram J, Shashindran CH, Koumaravelou K, Asad M (2001). Genetic polymorphism of CYP2D6 in Tamil population. Eur J Clin Pharmacol 56:849-50.

Abraham BK, Adithan C (2000). Endocrine Pharmacology.  Adithan C. Status report of Indian Pharmacological research 1994-1998, published by Indian National Science Academy, pp 68-80. 

Abraham BK, Adithan C, Kiran UP, Asad M, Koumaravelou K (2000). Genetic Polymorphism of CYP2D6 in Karnataka and Andhra Pradesh population. Acta Pharmacol Sin 21:494-8.

Abraham BK, Adithan C, Shashindran CH, Vasu S, Alekutty NA (2000). Genetic polymorphism of CYP2D6 in Keralite (South India) population. Br J Clin Pharmac 49:285-6.